IW 394

August 21, 2026 Viktor Zarev 0 min read
  1. Moderna shares double after successful trial for mRNA cancer vaccine.
  2. Doctors argue their role in the age of AI.
  3. Fitch says hospital cyberattacks are now a credit risk.
  4. Health systems scramble to plan ‘tokenomics’ for Epic’s AI cost model.
  5. Kaiser faces complaint over automated behavioral health triage.
  6. Temple Health CIO retires, on the hunt for permanent replacement. 
  7. Physicians feeling pressured to prioritize corporations over patients.
  8. VA-Oracle EHRM contract ceiling raises to nearly $27B.
  9. UNC Health launches strategic investment platform.
  10. Senate Democrats call on feds to stop sharing Medicaid data with ICE.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiogenetics September 10, 2026

Can Polygenic Risk Scores Uncover Hidden CVD? September 10, 2026

It’s rare that one gene causes CVD, just as it’s rare for one CV condition to occur in isolation. In a recent JACC issue, researchers show that […]

Cardiology Pharmaceuticals September 10, 2026

Novo, Novartis, and How Two Trials Cast Doubt on CVD Biomarkers September 10, 2026

Cardiology just took back-to-back blows to two of its most promising prevention strategies. One drug for lowering lipoprotein(a) and another targeting interleukin-6 both failed in major trials, even as fresh data reaffirms just how much those factors matter.

Surgeries & Interventions September 3, 2026

A Tale of Two Studies and the Importance of Patient Selection September 3, 2026

Two recent studies are forcing an important conversation in cardiology – some of the field's most common procedures may not be as clearly beneficial as open-label data originally suggests.